CAS Number 910376-39-5 ChemSpider 21378519 3D model (Jmol) Interactive image | PubChem CID 24857887 Formula C19H28N4O4 Molar mass 376.45 g/mol | |
 | ||
PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1. It was originally developed by Pfizer in 2008 as a medication for irritable bowel syndrome, but has only progressed to animal studies.
References
PF-03550096 Wikipedia(Text) CC BY-SA